Framingham风险评分与汇总队列方程的当代人群重新校准
重新校准使FRS女性风险高估从109%降至49%、男性从131%降至32%,并减少低危人群他汀处方、降低需治疗人数;而PCE重新校准后风险仍高估女性217%、男性128%。结论认为重新校准可行但依赖模型,FRS校准可改善风险预测和他汀使用。
要点
- FRS重新校准降低女性风险高估至49%、男性至32%。
- 校准后FRS减少低危女性26/1000、男性80/1000的他汀处方。
- PCE重新校准后风险仍高估女性217%、男性128%。
核心结论
- 重新校准是改善风险预测的可行方案,但效果取决于所用模型。
- 重新校准FRS而非PCE可减少风险高估并可能改善他汀使用。
研究设计与样本
- 使用2011年1月1日存活、30至79岁无心血管病的安大略居民队列重新校准5年FRS和PCE。
- 在2010年1月1日至2014年12月31日常规收集电子病历数据的初级保健队列中进行外部验证。
主要发现
- FRS在6,938,971名安大略居民(51.6%女性,平均年龄48岁)中重新校准,在71,450人(56.1%女性,平均年龄52岁)中验证。
- 重新校准使FRS女性风险高估从109%降至49%,男性从131%降至32%。
- 校准后FRS估计减少低危女性最多26/1000、低危男性最多80/1000的他汀处方。
- 校准后FRS使5年心血管事件需治疗人数女性从61降至47、男性从53降至41。
- PCE重新校准后风险仍高估女性217%、男性128%。
临床怎么用
- 在当代人群中可考虑对FRS进行重新校准以改善风险分层和他汀治疗分配。
- PCE重新校准后仍存在显著风险高估,需谨慎用于他汀决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Framingham Risk Score (FRS) and Pooled Cohort Equations (PCEs) overestimate risk in many contemporary cohorts. OBJECTIVES: This study sought to determine if recalibration of these scores using contemporary population-level data improves risk stratification for statin therapy. METHODS: Five-year FRS and PCEs were recalibrated using a cohort of Ontario residents alive January 1, 2011, who were 30 to 79 years of age without cardiovascular disease. Scores were externally validated in a primary care cohort of routinely collected electronic medical record data from January 1, 2010, to December 31, 2014. The relative difference in mean predicted and observed risk, number of statins avoided, and number needed to treat with statins to reduce a cardiovascular event at 5 years were reported. RESULTS: The FRS was recalibrated in 6,938,971 Ontario residents (51.6% women, mean age 48 years) and validated in 71,450 individuals (56.1% women, mean age 52 years). Recalibration reduced overestimation from 109% to 49% for women and 131% to 32% for men. The recalibrated FRS was estimated to reduce statin prescriptions in up to 26 per 1,000 low-risk women and 80 per 1,000 low-risk men, as well as reduce the number needed to treat from 61 to 47 in women and from 53 to 41 in men. In contrast, after recalibration of the PCEs, risk remained overestimated by 217% in women and 128% in men. CONCLUSIONS: Recalibration is a feasible solution to improve risk prediction but is dependent on the model being used. Recalibration of the FRS but not the PCEs reduced overestimation and may improve utilization of statins.
引用
- Sud M, Sivaswamy A, Chu A, et al. Population-Based Recalibration of the Framingham Risk Score and Pooled Cohort Equations. J Am Coll Cardiol. 2022. PMID: 36175052. doi:10.1016/j.jacc.2022.07.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。